Robert W. Baird analyst Eric Coldwell reiterated a Buy rating on AdaptHealth (AHCO – Research Report) on July 14 and set a price target of $26.00. The company's shares closed last Friday at $20.14. According to TipRanks.com, Coldwell is a 5-star analyst with an average return of 8.1% and a 51.0% success rate. Coldwell covers the Healthcare sector, focusing on stocks such as Quest Diagnostics, AmerisourceBergen, and Cardinal Health. Currently, the analyst consensus on AdaptHealth is a Strong Buy with an average price target of $25.13, implying a 25.9% upside from current levels.
https://www.tipranks.com/news/blurbs/adapthealth-ahco-gets-a-buy-rating-from-robert-w-baird?utm_source=advfn.com&utm_medium=referral
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more AdaptHealth Charts.
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more AdaptHealth Charts.